Cannabis finance news

Bod Science eyes new revenue streams after reporting heavy loss

by Steve Jones August 30, 2023August 30, 2023

Bod Science saw losses deepen 47% to almost A$8 million in FY23 as medical sales fell […]

Avecho raises another A$6m to fund trial as firm enters ‘defining chapter’

by Steve Jones August 28, 2023April 30, 2024

Cann Group losses deepen to almost A$34 million

by Steve Jones August 28, 2023April 30, 2024

International expansion on the cards as Vitura plots growth strategy

by Steve Jones August 24, 2023September 8, 2023

Vitura Health doubles profit with shareholders set for second dividend, but shares dip 10%

by Steve Jones August 23, 2023April 30, 2024

Company news: Astrid/CoCo; Medigrowth; Ecofibre

by Martin Lane August 22, 2023April 30, 2024

‘We’re at the start of our learning’, says Biortica MD as firm acquires Canadian genetics specialist

by Steve Jones August 9, 2023August 21, 2023

Medlab Clinical operations set to ‘conclude’ at EGM next month

by Steve Jones August 3, 2023April 30, 2024

Bod Science raises $1.9m to ease pressure on R&D costs

by Steve Jones August 3, 2023August 3, 2023

‘We’re financially secure,’ insists Cann Group boss after ASX poses questions

by Steve Jones August 3, 2023August 3, 2023